Clinical trials
Phase 2/3 trials in France with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 6 |
| University Hospital, Angers | 4 |
| University Hospital, Clermont-Ferrand | 3 |
| Hospices Civils de Lyon | 2 |
| University Hospital, Caen | 2 |
| 1Globe Health Institute LLC | 1 |
| Association Pour La Promotion A Tours De La Reanimation Medicale | 1 |
| Bambino Gesù Hospital and Research Institute | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre hospitalier de Ville-Evrard, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 2 |
| Pneumonia | 2 |
| Adenoma | 1 |
| Adenomatous Polyposis Coli | 1 |
| Adrenal Hyperplasia, Congenital | 1 |
| Alveolar Bone Loss | 1 |
| Aspergillosis | 1 |
| COVID-19 | 1 |
| Carcinoma, Embryonal | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.